{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:42:40Z","timestamp":1788385360770,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"the Congressionally Directed Medical Research Programs","doi-asserted-by":"crossref","award":["W81XWH2120457"],"award-info":[{"award-number":["W81XWH2120457"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Posttraumatic headache (PTH) is a common and debilitating symptom following repetitive mild traumatic brain injury (rmTBI), and it mainly resembles a migraine-like phenotype. While modulation of the endocannabinoid system (ECS) is effective in treating TBI and various types of pain including migraine, the role of augmentation of endocannabinoids in treating PTH has not been investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Repetitive mild TBI was induced in male C57BL\/6J mice using the non-invasive close-head impact model of engineered rotational acceleration (CHIMERA). Periorbital allodynia was assessed using von Frey filaments and determined by the \u201cUp-Down\u201d method. Immunofluorescence staining was employed to investigate glial cell activation and calcitonin gene-related peptide (CGRP) expression in the trigeminal ganglion (TG) and trigeminal nucleus caudalis (TNC) of the rmTBI mice. Levels of 2-arachidonoyl glycerol (2-AG), anandamide (AEA), and arachidonic acid (AA) in the TG, medulla (including TNC), and periaqueductal gray (PAG) were measured by mass spectrometry. The therapeutic effect of endocannabinoid modulation on PTH was also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The rmTBI mice exhibited significantly increased cephalic pain hypersensitivity compared to the sham controls. MJN110, a potent and selective inhibitor of the 2-AG hydrolytic enzyme monoacylglycerol lipase (MAGL), dose-dependently attenuated periorbital allodynia in the rmTBI animals. Administration of CGRP at 0.01\u00a0mg\/kg reinstated periorbital allodynia in the rmTBI animals on days 33 and 45 post-injury but had no effect in the sham and MJN110 treatment groups. Activation of glial cells along with increased production of CGRP in the TG and TNC at 7 and 14 days post-rmTBI were attenuated by MJN110 treatment. The anti-inflammatory and anti-nociceptive effects of MJN110 were partially mediated by cannabinoid receptor activation, and the pain-suppressive effect of MJN110 was completely blocked by co-administration of DO34, an inhibitor of 2-AG synthase. The levels of 2-AG in TG, TNC and PAG were decreased in TBI animals, significantly elevated and further reduced by the selective inhibitors of 2-AG hydrolytic and synthetic enzymes, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Enhancing endogenous levels of 2-AG appears to be an effective strategy for the treatment of PTH by attenuating pain initiation and transmission in the trigeminal pathway and facilitating descending pain inhibitory modulation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-024-01817-z","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T13:02:39Z","timestamp":1721134959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition of 2-AG hydrolysis alleviates posttraumatic headache attributed to mild traumatic brain injury"],"prefix":"10.1186","volume":"25","author":[{"given":"Jie","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiei","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"1817_CR1","doi-asserted-by":"publisher","unstructured":"Lucas S, Hoffman JM, Bell KR, andDikmen S (2014) A prospective study of prevalence and characterization of headache following mild traumatic brain injury Cephalalgia. 34:93\u2013102. https:\/\/doi.org\/10.1177\/0333102413499645","DOI":"10.1177\/0333102413499645"},{"key":"1817_CR2","doi-asserted-by":"publisher","unstructured":"Brown AW, Watanabe TK, Hoffman JM, Bell KR, Lucas S, andDikmen S (2015) Headache after traumatic brain injury: a national survey of clinical practices and treatment approaches PM R 7. 3\u20138. https:\/\/doi.org\/10.1016\/j.pmrj.2014.06.016","DOI":"10.1016\/j.pmrj.2014.06.016"},{"key":"1817_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41582-019-0243-8","volume":"15","author":"H Ashina","year":"2019","unstructured":"Ashina H, Porreca F, Anderson T, Amin FM, Ashina M, Schytz HW et al (2019) Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol 15:607\u2013617. https:\/\/doi.org\/10.1038\/s41582-019-0243-8","journal-title":"Nat Rev Neurol"},{"key":"1817_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/s0140-6736(79)92692-8","volume":"2","author":"MA Moskowitz","year":"1979","unstructured":"Moskowitz MA, Reinhard JF Jr., Romero J, Melamed E, andPettibone DJ (1979) Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet 2:883\u2013885. https:\/\/doi.org\/10.1016\/s0140-6736(79)92692-8","journal-title":"Lancet"},{"key":"1817_CR5","doi-asserted-by":"publisher","unstructured":"Tanaka M, andZhang Y (2022) Preclinical studies of Posttraumatic Headache and the potential therapeutics cells. 12. https:\/\/doi.org\/10.3390\/cells12010155","DOI":"10.3390\/cells12010155"},{"key":"1817_CR6","doi-asserted-by":"publisher","unstructured":"Guo Z, Czerpaniak K, Zhang J, andCao YQ (2021) Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache Pain. 162:1483\u20131499. https:\/\/doi.org\/10.1097\/j.pain.0000000000002147","DOI":"10.1097\/j.pain.0000000000002147"},{"key":"1817_CR7","doi-asserted-by":"publisher","unstructured":"Lu ZX, Dong BQ, Wei HL, andChen L (2022) Prediction and associated factors of non-steroidal anti-inflammatory drugs efficacy in migraine treatment front Pharmacol. 13:1002080. https:\/\/doi.org\/10.3389\/fphar.2022.1002080","DOI":"10.3389\/fphar.2022.1002080"},{"key":"1817_CR8","doi-asserted-by":"publisher","unstructured":"Visser WH, de Vriend RH, Jaspers NH, andFerrari MD (1996) Sumatriptan-nonresponders: a survey in 366 migraine patients Headache. 36:471\u2013475. https:\/\/doi.org\/10.1046\/j.1526-4610.1996.3608471.x","DOI":"10.1046\/j.1526-4610.1996.3608471.x"},{"key":"1817_CR9","doi-asserted-by":"publisher","unstructured":"Porreca F, Navratilova E, Hirman J, van den Brink AM, Lipton RB, andDodick DW (2024) Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex Cephalalgia. 44:3331024241238153. https:\/\/doi.org\/10.1177\/03331024241238153","DOI":"10.1177\/03331024241238153"},{"key":"1817_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","volume":"103","author":"AF Russo","year":"2023","unstructured":"Russo AF, andHay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103:1565\u20131644. https:\/\/doi.org\/10.1152\/physrev.00059.2021","journal-title":"Physiol Rev"},{"key":"1817_CR11","doi-asserted-by":"publisher","unstructured":"Donvito G, Nass SR, Wilkerson JL, Curry ZA, Schurman LD, Kinsey SG et al (2018) The endogenous cannabinoid system: a budding source of targets for treating Inflammatory and Neuropathic Pain Neuropsychopharmacology. 43:52\u201379. https:\/\/doi.org\/10.1038\/npp.2017.204","DOI":"10.1038\/npp.2017.204"},{"key":"1817_CR12","doi-asserted-by":"publisher","unstructured":"Greco R, Demartini C, Francavilla M, Zanaboni AM, andTassorelli C (2021) Dual inhibition of FAAH and MAGL counteracts migraine-like Pain and Behavior in an animal. Model Migraine Cells 10. https:\/\/doi.org\/10.3390\/cells10102543","DOI":"10.3390\/cells10102543"},{"key":"1817_CR13","doi-asserted-by":"publisher","unstructured":"Tchantchou F, Tucker LB, Fu AH, Bluett RJ, McCabe JT, Patel S et al (2014) The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury neuropharmacology. 85:427\u2013439. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.06.006","DOI":"10.1016\/j.neuropharm.2014.06.006"},{"key":"1817_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/jcbfm.2014.247","volume":"35","author":"J Zhang","year":"2015","unstructured":"Zhang J, Teng Z, Song Y, Hu M, andChen C (2015) Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury. J Cereb Blood Flow Metab 35:706. https:\/\/doi.org\/10.1038\/jcbfm.2014.247","journal-title":"J Cereb Blood Flow Metab"},{"key":"1817_CR15","doi-asserted-by":"publisher","unstructured":"Selvaraj P, Tanaka M, Wen J, andZhang Y (2021) The Novel Monoacylglycerol lipase inhibitor MJN110 suppresses Neuroinflammation, normalizes synaptic composition and improves behavioral performance in the repetitive traumatic brain Injury. Mouse Model Cells 10. https:\/\/doi.org\/10.3390\/cells10123454","DOI":"10.3390\/cells10123454"},{"key":"1817_CR16","doi-asserted-by":"publisher","unstructured":"Wen J, Sackett S, Tanaka M, andZhang Y (2023) Therapeutic effects of Combined Treatment with the AEA hydrolysis inhibitor PF04457845 and the substrate selective COX-2 inhibitor LM4131 in the mouse model of Neuropathic Pain cells. 12. https:\/\/doi.org\/10.3390\/cells12091275","DOI":"10.3390\/cells12091275"},{"key":"1817_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","volume":"204","author":"JR Savinainen","year":"2012","unstructured":"Savinainen JR, Saario SM, andLaitinen JT (2012) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol (Oxf) 204:267\u2013276. https:\/\/doi.org\/10.1111\/j.1748-1716.2011.02280.x","journal-title":"Acta Physiol (Oxf)"},{"key":"1817_CR18","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932\u20131936. https:\/\/doi.org\/10.1073\/pnas.87.5.1932","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1817_CR19","doi-asserted-by":"publisher","unstructured":"Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors Science. 310:329\u2013332. https:\/\/doi.org\/10.1126\/science.1115740","DOI":"10.1126\/science.1115740"},{"key":"1817_CR20","doi-asserted-by":"publisher","unstructured":"Sun J, Zhou YQ, Chen SP, Wang XM, Xu BY, Li DY et al (2019) The endocannabinoid system: novel targets for treating cancer induced bone pain Biomed Pharmacother. 120:109504. https:\/\/doi.org\/10.1016\/j.biopha.2019.109504","DOI":"10.1016\/j.biopha.2019.109504"},{"key":"1817_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1124\/jpet.115.222851","volume":"354","author":"S Ghosh","year":"2015","unstructured":"Ghosh S, Kinsey SG, Liu QS, Hruba L, McMahon LR, Grim TW et al (2015) Full fatty acid Amide Hydrolase Inhibition combined with partial Monoacylglycerol lipase inhibition: augmented and sustained Antinociceptive effects with reduced Cannabimimetic Side effects in mice. J Pharmacol Exp Ther 354:111\u2013120. https:\/\/doi.org\/10.1124\/jpet.115.222851","journal-title":"J Pharmacol Exp Ther"},{"key":"1817_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/WCO.0000000000000688","volume":"32","author":"C Tassorelli","year":"2019","unstructured":"Tassorelli C, Greco R, andSilberstein SD (2019) The endocannabinoid system in migraine: from bench to pharmacy and back. Curr Opin Neurol 32:405\u2013412. https:\/\/doi.org\/10.1097\/WCO.0000000000000688","journal-title":"Curr Opin Neurol"},{"key":"1817_CR23","doi-asserted-by":"publisher","unstructured":"Sarchielli P, Pini LA, Coppola F, Rossi C, Baldi A, Mancini ML et al (2007) Endocannabinoids in chronic migraine: CSF findings suggest a system failure Neuropsychopharmacology 32, 1384\u20131390 https:\/\/doi.org\/10.1038\/sj.npp.1301246","DOI":"10.1038\/sj.npp.1301246"},{"key":"1817_CR24","doi-asserted-by":"publisher","unstructured":"Greco R, Demartini C, Zanaboni AM, Piomelli D, andTassorelli C (2018) Endocannabinoid System and Migraine Pain: an Update Front Neurosci. 12:172. https:\/\/doi.org\/10.3389\/fnins.2018.00172","DOI":"10.3389\/fnins.2018.00172"},{"key":"1817_CR25","doi-asserted-by":"publisher","unstructured":"Russo EB (2016) Clinical Endocannabinoid Deficiency reconsidered: current research supports the theory in Migraine, Fibromyalgia, irritable bowel, and other treatment-resistant syndromes Cannabis Cannabinoid Res. 1:154\u2013165. https:\/\/doi.org\/10.1089\/can.2016.0009","DOI":"10.1089\/can.2016.0009"},{"key":"1817_CR26","doi-asserted-by":"publisher","unstructured":"Della Pietra A, Giniatullin R, andSavinainen JR (2021) Distinct activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key regions of Peripheral and Central Nervous System implicated in Migraine. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22031204","DOI":"10.3390\/ijms22031204"},{"key":"1817_CR27","doi-asserted-by":"publisher","unstructured":"Bree D, andLevy D (2018) Strides toward Better Understanding of Post-traumatic headache pathophysiology using animal models Curr Pain Headache Rep. 22:67. https:\/\/doi.org\/10.1007\/s11916-018-0720-6","DOI":"10.1007\/s11916-018-0720-6"},{"key":"1817_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-020-01135-0","volume":"21","author":"S Benemei","year":"2020","unstructured":"Benemei S, Labastida-Ramirez A, Abramova E, Brunelli N, Caronna E, Diana P et al (2020) Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence. J Headache Pain 21:90. https:\/\/doi.org\/10.1186\/s10194-020-01135-0","journal-title":"J Headache Pain"},{"key":"1817_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ejp.583","volume":"19","author":"T Benromano","year":"2015","unstructured":"Benromano T, Defrin R, Ahn AH, Zhao J, Pick CG, andLevy D (2015) Mild closed head injury promotes a selective trigeminal hypernociception: implications for the acute emergence of post-traumatic headache. Eur J Pain 19:621\u2013628. https:\/\/doi.org\/10.1002\/ejp.583","journal-title":"Eur J Pain"},{"key":"1817_CR30","doi-asserted-by":"publisher","unstructured":"Elliott MB, Oshinsky ML, Amenta PS, Awe OO, andJallo JI (2012) Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury headache. 52:966\u2013984. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02160.x","DOI":"10.1111\/j.1526-4610.2012.02160.x"},{"key":"1817_CR31","doi-asserted-by":"publisher","unstructured":"Feliciano DP, Sahbaie P, Shi X, Klukinov M, Clark JD, andYeomans DC (2014) Nociceptive sensitization and BDNF up-regulation in a rat model of traumatic brain injury Neurosci Lett. 583:55\u201359. https:\/\/doi.org\/10.1016\/j.neulet.2014.09.030","DOI":"10.1016\/j.neulet.2014.09.030"},{"key":"1817_CR32","doi-asserted-by":"publisher","unstructured":"Namjoshi DR, Cheng WH, McInnes KA, Martens KM, Carr M, Wilkinson A et al (2014) Merging pathology with biomechanics using CHIMERA (closed-Head Impact Model of Engineered Rotational Acceleration): a novel, surgery-free model of traumatic brain injury Mol Neurodegener. 9. https:\/\/doi.org\/10.1186\/1750-1326-9-55","DOI":"10.1186\/1750-1326-9-55"},{"key":"1817_CR33","doi-asserted-by":"crossref","unstructured":"McNamara EH, Grillakis AA, Tucker LB, McCabe JT (2020) The closed-head impact model of engineered rotational acceleration (CHIMERA) as an application for traumatic brain injury pre-clinical research: A status report. Exp Neurol. 333:113409.","DOI":"10.1016\/j.expneurol.2020.113409"},{"key":"1817_CR34","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/cn400116z","volume":"4","author":"MJ Niphakis","year":"2013","unstructured":"Niphakis MJ, Cognetta AB 3rd, Chang JW, Buczynski MW, Parsons LH, Byrne F et al (2013) Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. ACS Chem Neurosci 4:1322\u20131332. https:\/\/doi.org\/10.1021\/cn400116z","journal-title":"ACS Chem Neurosci"},{"key":"1817_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/jpet.114.222315","volume":"353","author":"B Ignatowska-Jankowska","year":"2015","unstructured":"Ignatowska-Jankowska B, Wilkerson JL, Mustafa M, Abdullah R, Niphakis M, Wiley JL et al (2015) Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice. J Pharmacol Exp Ther 353:424\u2013432. https:\/\/doi.org\/10.1124\/jpet.114.222315","journal-title":"J Pharmacol Exp Ther"},{"key":"1817_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, andYaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55\u201363. https:\/\/doi.org\/10.1016\/0165-0270(94)90144-9","journal-title":"J Neurosci Methods"},{"key":"1817_CR37","doi-asserted-by":"publisher","unstructured":"De Logu F, Landini L, Janal MN, Li Puma S, De Cesaris F, Geppetti P et al (2019) Migraine-provoking substances evoke periorbital allodynia in mice. J Headache Pain 20. https:\/\/doi.org\/10.1186\/s10194-019-0968-1","DOI":"10.1186\/s10194-019-0968-1"},{"key":"1817_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.neuroscience.2006.08.007","volume":"143","author":"H Smits","year":"2006","unstructured":"Smits H, Ultenius C, Deumens R, Koopmans GC, Honig WM, van Kleef M et al (2006) Effect of spinal cord stimulation in an animal model of neuropathic pain relates to degree of tactile allodynia. Neuroscience 143:541\u2013546. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.08.007","journal-title":"Neuroscience"},{"key":"1817_CR39","doi-asserted-by":"publisher","unstructured":"Bree D, andLevy D (2018) Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: implications for mechanisms of post-traumatic headache Cephalalgia. 38:246\u2013258. https:\/\/doi.org\/10.1177\/0333102416681571","DOI":"10.1177\/0333102416681571"},{"key":"1817_CR40","doi-asserted-by":"publisher","unstructured":"Navratilova E, Rau J, Oyarzo J, Tien J, Mackenzie K, Stratton J et al (2019) CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice Cephalalgia. 39:1762\u20131775. https:\/\/doi.org\/10.1177\/0333102419877662","DOI":"10.1177\/0333102419877662"},{"key":"1817_CR41","doi-asserted-by":"publisher","unstructured":"Wattiez AS, Castonguay WC, Gaul OJ, Waite JS, Schmidt CM, Reis AS et al (2021) Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles Pain. 162:1163\u20131175. https:\/\/doi.org\/10.1097\/j.pain.0000000000002103","DOI":"10.1097\/j.pain.0000000000002103"},{"key":"1817_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1073\/pnas.1522364112","volume":"113","author":"D Ogasawara","year":"2016","unstructured":"Ogasawara D, Deng H, Viader A, Baggelaar MP, Breman A, den Dulk H et al (2016) Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition. Proc Natl Acad Sci U S A 113:26\u201333. https:\/\/doi.org\/10.1073\/pnas.1522364112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1817_CR43","doi-asserted-by":"publisher","unstructured":"Zhang Q, Han X, Wu H, Zhang M, Hu G, Dong Z et al (2019) Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: relevant to migraine Mol Pain. 15:1744806918820452. https:\/\/doi.org\/10.1177\/1744806918820452","DOI":"10.1177\/1744806918820452"},{"key":"1817_CR44","doi-asserted-by":"publisher","unstructured":"Sturaro C, Fakhoury B, Targowska-Duda KM, Zribi G, Schoch J, Ruzza C et al (2023) Preclinical effects of cannabidiol in an experimental model of migraine Pain. 164:2540\u20132552. https:\/\/doi.org\/10.1097\/j.pain.0000000000002960","DOI":"10.1097\/j.pain.0000000000002960"},{"key":"1817_CR45","doi-asserted-by":"publisher","unstructured":"Araya EI, Turnes JM, Barroso AR, andChichorro JG (2020) Contribution of intraganglionic CGRP to migraine-like responses in male and female rats Cephalalgia. 40:689\u2013700. https:\/\/doi.org\/10.1177\/0333102419896539","DOI":"10.1177\/0333102419896539"},{"key":"1817_CR46","doi-asserted-by":"publisher","unstructured":"Tyburski AL, Cheng L, Assari S, Darvish K, andElliott MB (2017) Frequent mild head injury promotes trigeminal sensitivity concomitant with microglial proliferation, astrocytosis, and increased neuropeptide levels in the trigeminal pain system. J Headache Pain 18. https:\/\/doi.org\/10.1186\/s10194-017-0726-1","DOI":"10.1186\/s10194-017-0726-1"},{"key":"1817_CR47","doi-asserted-by":"crossref","unstructured":"Ashina H, Iljazi A, Al-Khazali HM, Christensen CE, Amin FM, Ashina M, Schytz HW (2020) Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache. Ann Neurol. 88(6):1220-1228.","DOI":"10.1002\/ana.25915"},{"key":"1817_CR48","doi-asserted-by":"crossref","unstructured":"Ashina H, Iljazi A, Al-Khazali HM, Do TP, Eigenbrodt AK, Larsen EL, Andersen AM, Hansen KJ, Br\u00e4uner KB, Chaudhry BA, Christensen CE, Amin FM, Schytz HW (2022) CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury. J Headache Pain. 23(1):135.","DOI":"10.1186\/s10194-022-01499-5"},{"key":"1817_CR49","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1089\/neu.2010.1672","volume":"28","author":"MB Elliott","year":"2011","unstructured":"Elliott MB, Tuma RF, Amenta PS, Barbe MF, andJallo JI (2011) Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury. J Neurotrauma 28:973\u2013981. https:\/\/doi.org\/10.1089\/neu.2010.1672","journal-title":"J Neurotrauma"},{"key":"1817_CR50","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jnr.23114","volume":"90","author":"PS Amenta","year":"2012","unstructured":"Amenta PS, Jallo JI, Tuma RF, andElliott MB (2012) A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res 90:2293\u20132305. https:\/\/doi.org\/10.1002\/jnr.23114","journal-title":"J Neurosci Res"},{"key":"1817_CR51","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/WCO.0000000000000815","volume":"33","author":"L Howard","year":"2020","unstructured":"Howard L, andSchwedt TJ (2020) Posttraumatic headache: recent progress. Curr Opin Neurol 33:316\u2013322. https:\/\/doi.org\/10.1097\/WCO.0000000000000815","journal-title":"Curr Opin Neurol"},{"key":"1817_CR52","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1124\/jpet.107.123745","volume":"322","author":"XC Zhang","year":"2007","unstructured":"Zhang XC, Strassman AM, Burstein R, andLevy D (2007) Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther 322:806\u2013812. https:\/\/doi.org\/10.1124\/jpet.107.123745","journal-title":"J Pharmacol Exp Ther"},{"key":"1817_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.neuint.2003.09.009","volume":"45","author":"J Wieseler-Frank","year":"2004","unstructured":"Wieseler-Frank J, Maier SF, andWatkins LR (2004) Glial activation and pathological pain. Neurochem Int 45:389\u2013395. https:\/\/doi.org\/10.1016\/j.neuint.2003.09.009","journal-title":"Neurochem Int"},{"key":"1817_CR54","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1523\/JNEUROSCI.2469-20.2020","volume":"41","author":"KG Witcher","year":"2021","unstructured":"Witcher KG, Bray CE, Chunchai T, Zhao F, O\u2019Neil SM, Gordillo AJ et al (2021) Traumatic brain Injury causes chronic cortical inflammation and neuronal dysfunction mediated by. Microglia J Neurosci 41:1597\u20131616. https:\/\/doi.org\/10.1523\/JNEUROSCI.2469-20.2020","journal-title":"Microglia J Neurosci"},{"key":"1817_CR55","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1523\/JNEUROSCI.2402-19.2020","volume":"40","author":"RJ Henry","year":"2020","unstructured":"Henry RJ, Ritzel RM, Barrett JP, Doran SJ, Jiao Y, Leach JB et al (2020) Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain Injury reduces neurodegeneration and neurological. Deficits J Neurosci 40:2960\u20132974. https:\/\/doi.org\/10.1523\/JNEUROSCI.2402-19.2020","journal-title":"Deficits J Neurosci"},{"key":"1817_CR56","doi-asserted-by":"publisher","unstructured":"Sommer C, andKress M (2004) Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia Neurosci Lett. 361:184\u2013187. https:\/\/doi.org\/10.1016\/j.neulet.2003.12.007","DOI":"10.1016\/j.neulet.2003.12.007"},{"key":"1817_CR57","doi-asserted-by":"publisher","unstructured":"Zhang XC, Kainz V, Burstein R, andLevy D (2011) Tumor necrosis factor-alpha induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions Pain. 152:140\u2013149. https:\/\/doi.org\/10.1016\/j.pain.2010.10.002","DOI":"10.1016\/j.pain.2010.10.002"},{"key":"1817_CR58","doi-asserted-by":"publisher","unstructured":"Antonova M, Wienecke T, Olesen J, andAshina M (2012) Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura Cephalalgia 32, 822\u2013833 https:\/\/doi.org\/10.1177\/0333102412451360","DOI":"10.1177\/0333102412451360"},{"key":"1817_CR59","doi-asserted-by":"publisher","first-page":"e17360","DOI":"10.1371\/journal.pone.0017360","volume":"6","author":"L Neeb","year":"2011","unstructured":"Neeb L, Hellen P, Boehnke C, Hoffmann J, Schuh-Hofer S, Dirnagl U et al (2011) IL-1beta stimulates COX-2 dependent PGE(2) synthesis and CGRP release in rat trigeminal ganglia cells. PLoS ONE 6:e17360. https:\/\/doi.org\/10.1371\/journal.pone.0017360","journal-title":"PLoS ONE"},{"key":"1817_CR60","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","volume":"14","author":"S Eftekhari","year":"2013","unstructured":"Eftekhari S, Warfvinge K, Blixt FW, andEdvinsson L (2013) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain 14:1289\u20131303. https:\/\/doi.org\/10.1016\/j.jpain.2013.03.010","journal-title":"J Pain"},{"key":"1817_CR61","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1523\/JNEUROSCI.0576-17.2017","volume":"37","author":"A Melo-Carrillo","year":"2017","unstructured":"Melo-Carrillo A, Noseda R, Nir RR, Schain AJ, Stratton J, Strassman AM et al (2017) Selective inhibition of Trigeminovascular neurons by Fremanezumab: a humanized monoclonal Anti-CGRP. Antib J Neurosci 37:7149\u20137163. https:\/\/doi.org\/10.1523\/JNEUROSCI.0576-17.2017","journal-title":"Antib J Neurosci"},{"key":"1817_CR62","doi-asserted-by":"publisher","unstructured":"Eftekhari S, Salvatore CA, Calamari A, Kane SA, Tajti J, andEdvinsson L (2010) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion neuroscience. 169:683\u2013696. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.05.016","DOI":"10.1016\/j.neuroscience.2010.05.016"},{"key":"1817_CR63","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"JK Lennerz","year":"2008","unstructured":"Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277\u20131299. https:\/\/doi.org\/10.1002\/cne.21607","journal-title":"J Comp Neurol"},{"key":"1817_CR64","doi-asserted-by":"publisher","unstructured":"Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y, Ji RR et al (2006) Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist Pain. 124:175\u2013183. https:\/\/doi.org\/10.1016\/j.pain.2006.04.001","DOI":"10.1016\/j.pain.2006.04.001"},{"key":"1817_CR65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, andDi Marzo V (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 16:9\u201329. https:\/\/doi.org\/10.1038\/s41582-019-0284-z","journal-title":"Nat Rev Neurol"},{"key":"1817_CR66","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1523\/JNEUROSCI.18-08-02834.1998","volume":"18","author":"DE Garcia","year":"1998","unstructured":"Garcia DE, Brown S, Hille B, andMackie K (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 18:2834\u20132841. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-08-02834.1998","journal-title":"J Neurosci"},{"key":"1817_CR67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3389\/fncel.2014.00426","volume":"8","author":"D Ladarre","year":"2014","unstructured":"Ladarre D, Roland AB, Biedzinski S, Ricobaraza A, andLenkei Z (2014) Polarized cellular patterns of endocannabinoid production and detection shape cannabinoid signaling in neurons. Front Cell Neurosci 8:426. https:\/\/doi.org\/10.3389\/fncel.2014.00426","journal-title":"Front Cell Neurosci"},{"key":"1817_CR68","doi-asserted-by":"publisher","unstructured":"Amenta PS, Jallo JI, Tuma RF, Hooper DC, andElliott MB (2014) Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury. J Neuroinflammation 11. https:\/\/doi.org\/10.1186\/s12974-014-0191-6","DOI":"10.1186\/s12974-014-0191-6"},{"key":"1817_CR69","doi-asserted-by":"publisher","unstructured":"Oubraim S, Wang R, Hausknecht KA, Shen RY, andHaj-Dahmane S (2021) Tonic Endocannabinoid Signaling Gates synaptic plasticity in dorsal raphe nucleus serotonin neurons through peroxisome proliferator-activated receptors Front Pharmacol. 12:691219. https:\/\/doi.org\/10.3389\/fphar.2021.691219","DOI":"10.3389\/fphar.2021.691219"},{"key":"1817_CR70","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR et al (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2. Pharmacol Rev 62:588\u2013631. https:\/\/doi.org\/10.1124\/pr.110.003004","journal-title":"Pharmacol Rev"},{"key":"1817_CR71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-016-0644-7","volume":"17","author":"M Dux","year":"2016","unstructured":"Dux M, Deak E, Tassi N, Santha P, andJancso G (2016) Endovanilloids are potential activators of the trigeminovascular nocisensor complex. J Headache Pain 17:53. https:\/\/doi.org\/10.1186\/s10194-016-0644-7","journal-title":"J Headache Pain"},{"key":"1817_CR72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fncel.2020.00135","volume":"14","author":"A Suleimanova","year":"2020","unstructured":"Suleimanova A, Talanov M, Gafurov O, Gafarov F, Koroleva K, Virenque A et al (2020) Modeling a nociceptive Neuro-Immune Synapse activated by ATP and 5-HT in meninges: Novel clues on Transduction of Chemical signals into persistent or rhythmic neuronal. Firing Front Cell Neurosci 14:135. https:\/\/doi.org\/10.3389\/fncel.2020.00135","journal-title":"Firing Front Cell Neurosci"},{"key":"1817_CR73","doi-asserted-by":"publisher","first-page":"644047","DOI":"10.3389\/fncel.2021.644047","volume":"15","author":"A Suleimanova","year":"2021","unstructured":"Suleimanova A, Talanov M, van den Maagdenberg A, andGiniatullin R (2021) Deciphering in silico the role of mutated na (V) 1.1 Sodium channels in enhancing trigeminal nociception in familial hemiplegic migraine type 3. Front Cell Neurosci 15:644047. https:\/\/doi.org\/10.3389\/fncel.2021.644047","journal-title":"Front Cell Neurosci"},{"key":"1817_CR74","doi-asserted-by":"publisher","unstructured":"Romero LO, Massey AE, Mata-Daboin AD, Sierra-Valdez FJ, Chauhan SC, Cordero-Morales JF et al (2019) Dietary fatty acids fine-tune Piezo1 mechanical response Nat Commun. 10. https:\/\/doi.org\/10.1038\/s41467-019-09055-7","DOI":"10.1038\/s41467-019-09055-7"},{"key":"1817_CR75","doi-asserted-by":"publisher","first-page":"ra15","DOI":"10.1126\/scisignal.2005667","volume":"8","author":"I Borbiro","year":"2015","unstructured":"Borbiro I, Badheka D, andRohacs T (2015) Activation of TRPV1 channels inhibits mechanosensitive Piezo channel activity by depleting membrane. Phosphoinositides Sci Signal 8:ra15. https:\/\/doi.org\/10.1126\/scisignal.2005667","journal-title":"Phosphoinositides Sci Signal"},{"key":"1817_CR76","first-page":"31","volume":"25","author":"EB Russo","year":"2004","unstructured":"Russo EB (2004) Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett 25:31\u201339. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15159679","journal-title":"Neuro Endocrinol Lett"},{"key":"1817_CR77","doi-asserted-by":"publisher","first-page":"1171188","DOI":"10.3389\/fpain.2023.1171188","volume":"4","author":"E Liktor-Busa","year":"2023","unstructured":"Liktor-Busa E, Levine AA, Palomino SM, Singh S, Wahl J, Vanderah TW et al (2023) ABHD6 and MAGL control 2-AG levels in the PAG and allodynia in a CSD-induced periorbital model of headache. Front Pain Res (Lausanne) 4:1171188. https:\/\/doi.org\/10.3389\/fpain.2023.1171188","journal-title":"Front Pain Res (Lausanne)"},{"key":"1817_CR78","doi-asserted-by":"publisher","unstructured":"Leimuranta P, Khiroug L, andGiniatullin R (2018) Emerging role of (Endo)cannabinoids in Migraine Front Pharmacol. 9:420. https:\/\/doi.org\/10.3389\/fphar.2018.00420","DOI":"10.3389\/fphar.2018.00420"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01817-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01817-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01817-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T13:02:45Z","timestamp":1721134965000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01817-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01817-z","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal care and experimental procedures were carried out in accordance with NIH guidelines and approved by the Uniformed Services University Animal Care and Use Committee (IACUC), and the Animal Care and Use Review Office (ACUCO) from the United States Department of Defense (DoD).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}